<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03171311</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-161-16</org_study_id>
    <nct_id>NCT03171311</nct_id>
  </id_info>
  <brief_title>The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)</brief_title>
  <acronym>OCTOBER</acronym>
  <official_title>European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction - The OCTOBER Trial -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to compare median two-year clinical outcome after OCT guided vs. standard
      guided revascularization of patients requiring complex bifurcation stent implantation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary bifurcation lesions with stenosis in a large side branch may require complex stent
      implantation techniques with an elevated risk of suboptimal treatment results. Intra vascular
      optical coherence tomography (OCT) enables improved procedural control of correctable factors
      and may lead to optimized implantation results.

      It is unknown if routine, systematic use of OCT scans during complex bifurcation stenting
      improves clinical outcome but present available evidence indicates advantages of OCT guidance
      that could translate into improved clinical outcome.

      Hypothesis: Systematic OCT guided revascularization of patients with bifurcation lesions
      requiring complex stent implantation provides superior two-year clinical outcome compared to
      standard revascularization by PCI.

      Methods: Investigator initiated and investigator sponsored, randomized (1:1), controlled,
      prospective, multicenter, superiority trial. Randomization is stratified for 1) Left main or
      non-Left main artery disease, and 2) up-front planned one-stent technique with kissing
      balloon inflation, or a two-stent technique.

      Systematic OCT guidance is detailed for five complex stent implantation techniques. Standard
      treatment is angiographic based with optional use of intravascular ultrasound (IVUS).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Anticipated">May 2029</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined endpoint of major adverse cardiovascular events (MACE)</measure>
    <time_frame>24 months</time_frame>
    <description>cardiac death, target lesion myocardial infarction, ischaemic driven target lesion revascularization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>1 month</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>24 months</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>36 months</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>48 months</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study bifurcation oriented composite endpoint of MACE</measure>
    <time_frame>60 months</time_frame>
    <description>Composite of cardiac death, target bifurcation myocardial infarction, target bifurcation revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>1 month</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>12 months</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>24 months</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>36 months</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>48 months</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient oriented composite endpoint endpoint of MACE</measure>
    <time_frame>60 months</time_frame>
    <description>All cause mortality, myocardial infarction, any revascularisation, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>1 month</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>12 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>24 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>36 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>48 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>60 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>120 months</time_frame>
    <description>Death of any cause including cardiac deaths and non-natural causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>1 month</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>12 months</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>24 months</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>36 months</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>48 months</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>60 months</time_frame>
    <description>Death due to cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 month</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>12 months</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>24 months</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>36 months</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>48 months</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>60 months</time_frame>
    <description>Procedure and non-procedure related myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>1 month</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>12 months</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>24 months</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>36 months</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>48 months</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>60 months</time_frame>
    <description>Definite, possible or probable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>1 month</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>12 months</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>24 months</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>36 months</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>48 months</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion myocardial infarction</measure>
    <time_frame>60 months</time_frame>
    <description>Myocardial infarction related to an index treated lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>1 month</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>12 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>24 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>36 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>48 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>60 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>1 month</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>12 months</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>24 months</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>36 months</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>48 months</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation myocardial infarction</measure>
    <time_frame>60 months</time_frame>
    <description>Myocardial infarction related to the index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>1 month</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>12 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>24 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>36 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>48 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target bifurcation revascularisation</measure>
    <time_frame>60 months</time_frame>
    <description>Coronary artery bypass grafting or PCI of index bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>1 month</time_frame>
    <description>Coronary artery bypass grafting or PCI related to target vessel lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>12 months</time_frame>
    <description>Coronary artery bypass grafting or PCI related to target vessel lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>36 months</time_frame>
    <description>Coronary artery bypass grafting or PCI related to target vessel lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>48 months</time_frame>
    <description>Coronary artery bypass grafting or PCI related to target vessel lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>60 months</time_frame>
    <description>Coronary artery bypass grafting or PCI related to target vessel lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>1 month</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>12 months</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>24 months</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>36 months</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>48 months</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any revascularisation</measure>
    <time_frame>60 months</time_frame>
    <description>Any repeat revascularization except staged procedures planned at the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>1 month</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>12 months</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>24 months</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>36 months</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>48 months</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS angina class</measure>
    <time_frame>60 months</time_frame>
    <description>Canadian Cardiovascular Society (CCS) grading of angina pectoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>1 month</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>12 months</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>24 months</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>36 months</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>48 months</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>60 months</time_frame>
    <description>New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal lumen area in proximal main vessel segment</measure>
    <time_frame>1 day</time_frame>
    <description>Minimal lumen area by 3D quantitative coronary analysis (QCA) in the stented segment including edge just proximal to the target bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal lumen area in distal main vessel segment</measure>
    <time_frame>1 day</time_frame>
    <description>Minimal lumen area by 3D quantitative coronary analysis (QCA) in the stented segment including edge just distal to the target bifurcation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal lumen area in the side branch segment</measure>
    <time_frame>1 day</time_frame>
    <description>Minimal lumen area by 3D quantitative coronary analysis (QCA) in the proximal stented or balloon treated side branch segment including edge, of the target bifurcation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Ischaemic Heart Disease</condition>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Angiographic guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Angiographic guided PCI is revascularization by percutaneous coronary intervention (PCI) and optional use of intravascular ultrasound (IVUS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCT guided PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>OCT guided PCI is percutaneous coronary intervention (PCI) guided by systematic use of intravascular optical coherence tomography (OCT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Angiographic guided PCI</intervention_name>
    <description>Angiographic guided PCI is percutaneous coronary intervention performed by standard angiographic guided techniques</description>
    <arm_group_label>Angiographic guided PCI</arm_group_label>
    <other_name>PCI, percutaneous transluminal coronary angioplasty (PTCA)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT guided PCI</intervention_name>
    <description>OCT guided PCI is percutaneous coronary intervention (PCI) guided by intra vascular optical coherence tomography (OCT) scans</description>
    <arm_group_label>OCT guided PCI</arm_group_label>
    <other_name>OCT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable angina pectoris, unstable angina pectoris, clinically stable non-STEMI.

          -  Age ≥18 yrs.

          -  Abel to provide written Informed consent and willing to comply with the specified
             follow-up contacts.

        Angiographic inclusion criteria:

          -  Native coronary bifurcation de novo lesion

          -  More than 50% diameter stenosis in the main vessel (MV)

          -  More than 50% diameter stenosis in the side branch (SB) within 5 mm of the ostium.

          -  Reference size at least 2.75 mm in the main vessel (MV) and ≥2.5 mm in the SB.

        Functional inclusion criteria:

        Functional significance of the main vessel lesion or documented ischemia of the main vessel
        territory or other objective documentation of lesion significance. Objective evidence of
        ischemia is required for all treated lesions except for lesions with more than 80% diameter
        stenosis that may be considered significant.

        Procedural inclusion criteria:

        Indication for two-stent technique or one-stent technique with kissing balloon inflation

        Exclusion Criteria:

          -  STEMI within 72 hours

          -  Cardiogenic shock

          -  Prior coronary artery bypass grafting (CABG) or planned CABG

          -  Renal failure with glomerular filtration rate (GFR) &lt;50 mL/min per 1.73 m2

          -  Active bleeding or coagulopathy

          -  Life expectancy &lt; 2 years

          -  Ejection fraction &lt; 30%

          -  New York Heart Association (NYHA) class &gt; II

          -  Relevant allergies (aspirin, clopidogrel, ticagrelor, contrast compounds, everolimus).

        Angiographic exclusion criteria:

          -  Severe tortuosity around target bifurcation

          -  Chronic total occlusions

          -  Massive thrombus in Left main coronary artery

          -  Medina 0.0.1 lesions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evald H Christiansen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evald H Christiansen, MD, PhD</last_name>
    <phone>+4578450000</phone>
    <phone_ext>52028</phone_ext>
    <email>evald.christiansen@dadlnet.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niels R Holm, MD</last_name>
    <phone>+4578450000</phone>
    <phone_ext>52054</phone_ext>
    <email>niels.holm@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evald H Christiansen, MD, PhD</last_name>
      <phone>+4578450000</phone>
      <phone_ext>52028</phone_ext>
      <email>evald.christiansen@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Niels R Holm, MD</last_name>
      <phone>+4578450000</phone>
      <phone_ext>52054</phone_ext>
      <email>niels.holm@clin.au.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niels T Olsen, MD</last_name>
      <email>niels.thue.olsen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>København Ø</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens F Lassen, MD</last_name>
      <email>jens.flensted.lassen@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Engstrøm</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisette O Jensen, MD</last_name>
      <email>okkels@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Karsten T Veien, MD</last_name>
      <email>karsten.veien@rsyd.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zealand University Hospital, Roskilde Sygehus</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ole Haunstrup, MD</last_name>
      <email>oha@regionsjaelland.dk</email>
    </contact>
    <contact_backup>
      <last_name>Henning Kelbæk, MD</last_name>
      <email>h.kelbaek@dadlnet.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Estonia Medical Centre</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peep Laanmets, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>FI00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mika Laine, MD</last_name>
      <email>mika.laine@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HYH-Peijas Hospital, Vanta</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juha Heikkilä, MD</last_name>
      <email>juha-pekka.heikkila@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HYKS-Meilahti HospitaI</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juho Viikilä, MD</last_name>
      <email>juho.viikila@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kokkola Central Hospital</name>
      <address>
        <city>Kokkola</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jussi Sia, MD</last_name>
      <email>jussi.sia@kpshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hannu Romppanen, MD</last_name>
      <email>romppaha@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Juha Hartikainen, MD</last_name>
      <email>juha.hartikainen@kuh.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pasi Karjalainen, MD</last_name>
      <email>pastori.karjalainen@pp.inet.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olli Kajander, MD</last_name>
      <email>Olli.Kajander@sydankeskus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mikko Pietilä, MD</last_name>
      <email>mikko.pietila@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Holger Nef, MD</last_name>
      <email>holger.nef@innere.med.uni-giessen.de</email>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>9</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Foley, MD</last_name>
      <email>davidfoley@beaumont.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Galway</name>
      <address>
        <city>Galway</city>
        <zip>H91YR71</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Darren Mylotte, MD</last_name>
      <email>darrenmylotte@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemelli General Hospital, Catholic University of the Sacred Heart</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Burzotta, MD</last_name>
      <email>francesco.burzotta@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Latvia Centre of Cardiology</name>
      <address>
        <city>Riga</city>
        <zip>LV-1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Indulis Kumsars, MD</last_name>
      <email>indulis.kumsars@stradini.lv</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of Southern Norway, Arendal</name>
      <address>
        <city>Arendal</city>
        <zip>4604</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Slobodan Calic, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital, Bergen</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Øyvind Bleie, MD, PhD</last_name>
      <email>oyvind.bleie@helse-bergen.no</email>
    </contact>
    <contact_backup>
      <last_name>Erlend Eriksen, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Akerhus Universitetssykehus</name>
      <address>
        <city>Loerenskog</city>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margido A Husvik, MD</last_name>
      <email>margido.andre.husvik@ahus.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Eek, MD</last_name>
      <email>sbeekc@ous-hf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital - Ullevål</name>
      <address>
        <city>Oslo</city>
        <zip>0450</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pavel Hoffmann, MD</last_name>
      <email>PAVHOF@ous-hf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital</name>
      <address>
        <city>Stavanger</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nigussie Bogale, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Trondheim University Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Heigert, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Rune Wiseth, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Region Gavleborg</name>
      <address>
        <city>Gävle</city>
        <zip>801 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Kastberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacob Odenstedt, MD</last_name>
      <email>jacob.odenstedt@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Orebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ole Frøbert, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nils Witt, MD</last_name>
      <email>nils.witt@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loghman Henareh, MD</last_name>
      <email>loghman.henareh@karolinska.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danderyd Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>182 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rickard Linder, MD</last_name>
      <email>Rickard.linder@ds.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan James, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Belfast Health and Social Care Trust</name>
      <address>
        <city>Belfast</city>
        <zip>BT9 7AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon J Walsh, MD</last_name>
      <email>simon.j.walsh@btinternet.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <zip>BH77DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter O'Kane, MD</last_name>
      <email>peter.o'kane@rbch.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sussex Cardiac Centre</name>
      <address>
        <city>Brighton</city>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Cockburn, MD</last_name>
      <email>James.Cockburn@bsuh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bristol University Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS1 3NU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Johnson, MD</last_name>
      <email>twj1974@doctors.org.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Forth Valley Royal Hospital</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James C Spratt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G81 4DY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stuart Watkins, MD</last_name>
      <email>stuart.watkins@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan Hill, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital South Manchester, Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M239LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Saqib Chowdhary, MD</last_name>
      <email>saqib.chowdhary@uhsm.nh.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrian Banning, MD</last_name>
      <email>adrian.banning@ouh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton, General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nick Curzen, MD</last_name>
      <email>nick.curzen@suht.swest.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Cotton, MD</last_name>
      <email>james.cotton@rwh-tr.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Latvia</country>
    <country>Norway</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Evald Hoej Christiansen</investigator_full_name>
    <investigator_title>MD, phd</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Is decided after primary endpoint assessment and requires regulatory approval</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

